Specific clinical scenarios where injections are the standard of care include pernicious anemia, severe malabsorption syndromes, post-bariatric surgery when oral supplementation has failed, and critically low serum B12 levels accompanied by neurological deterioration
See our full regulatory breakdown: PCAC Peptide Review 2026
The practice's published peptide catalog is organized into four functional categories: Repair and recovery BPC-157, TB-500, and Thymosin -4, used alongside orthobiologic procedures to extend the repair window Metabolic and growth CJC-1295, Ipamorelin, semaglutide, and tirzepatide, directed at insulin resistance and the inflammatory burden it sustains Longevity and cognition MOTS-c, SS-31, Epitalon, Dihexa, and Selank, addressing mitochondrial efficiency and immune recalibration Sleep, skin, and vitality DSIP, GHK-Cu, and PT-141, targeting sleep architecture, collagen signaling, and libido Peptide therapy is offered alongside the practice's orthobiologics program and its work in metabolic inflammation
Key Features
Concerns about potential teratogenicity (birth defects), effects on pregnancy, or safety during lactation have not been adequately studied, so use during pregnancy or breastfeeding is not recommended absent compelling indication and appropriate medical supervision
PMCID: PMC9531956